Patent US2448288A successfully refreshed from Google Patents.
Patent US5032407A successfully refreshed from Google Patents.
US5032407A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Gene transfer using transformed, neodetermined, embryonic cells
Assignee: OHIO UNIVERSITY EDISON ANIMAL BIOTECHNOLOGY CENTER A BRANCH OF STATE OF GOVERNMENT OF STATE OF OH
•
Filing: 1987-01-16
•
Granted: 1991-07-16
•
Expires: 2007-01-16
Abstract
Abstract This invention is directed to a method for the preparation of carrier cells capable of delivering exogenous genetic material to a particular tissue of the body by means of embryonic cells competent to develop into that tissue, and essentially only that tissue, said cells bearing the exogenous genetic material. The preferred carrier cells are mesodermal cells of the yolk sac or embryonic forebrain or midbrain cells, and the desired genetic material is preferably introduced into the cells by in vitro transformation with an amphotrophic retroviral vector.
Inventors
- 👤 Thomas E. Wagner
- 👤 Michael A. Reed
- 👤 Barbara J. Corn
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 11:04
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0603; C12N5/0605; A; A61; A61K; A61K48/00; C12N2510/00
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
98 words
A method of providing tissue-specific expression of exogenous genetic material is selected tissues of a recipient mammal which comprises: (a) providing carrier cells capable of selectively delivering said exogenous genetic material to said tissues, said cells selected from the group consisting of embryonic yolk sac cells, embryonic midbrain cells and embryonic forebrain cells, all of which are derived from a donor mammal of the same species, said cells also having been transformed in vitro with said exogenous genetic material and (b) introducing said cells into said recipient mammal in a manner permitting them to differentiate into said tissues.
Claim 2
Independent Claim
98 words
A method of providing tissue-specific expression of exogenous genetic material is selected tissues of a recipient mammal which comprises: (a) providing carrier cells capable of selectively delivering said exogenous genetic material to said tissues, said cells selected from the group consisting of embryonic yolk sac cells, embryonic midbrain cells and embryonic forebrain cells, all of which are derived from a donor mammal of the same species, said cells also having been transformed in vitro with said exogenous genetic material and (b) introducing said cells into said recipient mammal in a manner permitting them to differentiate into said tissues.
Claim 3
Dependent Claim
31 words
The method of claim 1, where the carrier cells are mesodermal cells of the yolk sac which are competent to develop into hematopoietic stem cells, and the cells are introduced intravenously.
Claim 4
Dependent Claim
15 words
The method of claim 1, where the carrier cells are embryonic forebrain or midbrain cells.
Claim 5
Dependent Claim
18 words
The method of claim 1, where the cells are transformed with a retroviral vector carrying the genetic material.
Claim 6
Dependent Claim
11 words
The method of claim 4, where the retroviral vector is amphotrophic.
Claim 7
Dependent Claim
24 words
The method of claim 1 where the animal is immunocompetent and the introduction of the carrier cells does not result in an immune response.
Claim 8
Dependent Claim
27 words
The method of claim 1, said cells being essentially histocompatible with a host of the same species as the mammal from which the embryonic cells were derived.
Claim 9
Dependent Claim
14 words
The method of claim 1 in which the embryonic cells provided have been immortalized.
Claim 10
Dependent Claim
17 words
The method of claim 1, wherein the cells of the tissue are deficient in said genetic material.
Claim 11
Dependent Claim
17 words
The method of claim 1, where the cells are transformed by microinjecting them with the genetic material.
Claim 12
Dependent Claim
39 words
The method of claim 1 wherein the carrier cells are at a sufficiently early stage of development so that introduction of the carrier cells into an immunocompetent mammal does not result in an immune response to said carrier cells.
Claim 13
Dependent Claim
10 words
The method of claim 11 wherein the mammal is immunocompetent.
Claim 14
Dependent Claim
34 words
The method of claim 1 wherein the carrier cells are yolk sac cells derived from yolk sacs extracted from an embryonic donor mammal prior to the formation of blood islands visible at 12X magnification.
Claim 15
Dependent Claim
36 words
A process for producing a chimeric mammal characterized by the presence of heterologous genetic material in selected tissues of said mammal, which comprises introducing heterologous genetic material into said tissues by the method of claim 1.
Claim 16
Dependent Claim
16 words
The method of claim 1 wherein the carrier cells are provided in a non-enzymatically disaggregated form.
References Cited (Backward Citations)
US4497796A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-07-15 | 1995-01-14 | 1995-07-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-07-15 | 1999-01-14 | 1999-07-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-07-15 | 2003-01-14 | 2003-07-16 | $7700.00 | Window Closed / Lapsed |